Signal
New computational and experimental approaches identify drug repurposing candidates for neurological disorders
Recent studies have integrated genomic, transcriptomic, and proteomic data with network pharmacology and transcriptome-wide association analyses to identify drug repurposing candidates for Alzheimer's disease and long-term stroke recovery.
rss
clinical_trialsdrug_developmentgenomicsr_and_dsafety_signals
Evidence locked
Today's free sample is only available for the edition's flagship signal.
Evidence preview
- bioRxiv study on drug repurposing for Alzheimer's disease using network pharmacologybiorxiv.org
- Transcriptomics-Guided Drug Repurposing Identifies Candidate Compounds for Improving Long-Term Stroke OutcomemedRxiv (all subjects)
- Rejuvenation of the Aged Cerebrovascular System via Protein Corona-Guided Fusogenic Liposome DeliverybioRxiv (all subjects)